AstraZeneca Pharma India Ltd. — Regulatory Filings 2022

Dec 15, 2022

==> picture [524 x 91] intentionally omitted <==

December 15, 2022

The Manager - Listing National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai - 400051

The Manager - Listing BSE Limited Corporate Relationship Dept., 1[st] Floor, New Trading Ring, Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai - 400001

Dear Sir(s),

Sub: Closure of Trading Window

This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, read with AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Equity Shares of the Company will be closed from December 16, 2022 and the same shall reopen after 48 hours from the declaration of Unaudited Financial Results of the Company for the quarter ending December 31, 2022.

We request you to please take the same on record.

Thanking you,

Yours faithfully,

For AstraZeneca Pharma India Limited

Digitally signed MANAS by MANASA RAMA A RAMA Date: 2022.12.15 16:25:12 +05'30'

Manasa. R Company Secretary

==> picture [452 x 64] intentionally omitted <==